Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / PFE - Exelixis: Beyond The Cabozantinib Franchise


PFE - Exelixis: Beyond The Cabozantinib Franchise

  • Driven by their blockbuster Cabo, Exelixis generated $1.43B in total revenues translating to a 45.3% year-over-year (YOY) increase.
  • For further growth, the company is expanding Cabo's label in multiple ongoing Phase 3 investigations.
  • Aside from Cabo, Exelixis is tinkering with small molecules, antibody-drug conjugates and other biotherapeutics that are addressing highly promising targets.

For further details see:

Exelixis: Beyond The Cabozantinib Franchise
Stock Information

Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com

Menu

PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...